BioNexus Gene Lab Corp
NASDAQ:BGLC
BioNexus Gene Lab Corp
Inventory
BioNexus Gene Lab Corp
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
BioNexus Gene Lab Corp
NASDAQ:BGLC
|
Inventory
$1m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
119%
|
CAGR 10-Years
N/A
|
|
BioNexus Gene Lab Corp
Glance View
BioNexus Gene Lab Corp. is a molecular diagnostics company, which focuses on the application of functional genomics to enable diagnosis and personalized health management. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan and currently employs 8 full-time employees. The company went IPO on 2020-03-11. The firm is focused on the application of functional genomics to enable early diagnosis and personalized health management. The firm's wholly owned subsidiaries include Bionexus Gene Lab Sdn. Bhd. (Bionexus Malaysia) and Chemrex Sdn. Bhd. (Chemrex). BioNexus Malaysia owns algorithm software, technology and know-how related to the detection of common diseases through blood analysis which it uses in its business. Its non-invasive blood screening tests analyze changes in ribonucleic acid (RNA) to detect the risk potentiality of approximately 11 different diseases. These diseases include cancers, bowel diseases and osteoarthritis. Chemrex is a wholesaler of industrial chemicals for the manufacture of industrial, medical, appliance, aero, automotive, mechanical and electronic industries in Asia Pacific region.
See Also
What is BioNexus Gene Lab Corp's Inventory?
Inventory
1m
USD
Based on the financial report for Sep 30, 2025, BioNexus Gene Lab Corp's Inventory amounts to 1m USD.
What is BioNexus Gene Lab Corp's Inventory growth rate?
Inventory CAGR 5Y
119%
Over the last year, the Inventory growth was -27%. The average annual Inventory growth rates for BioNexus Gene Lab Corp have been -3% over the past three years , 119% over the past five years .
